Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Precio Fishbone B | PRCOB | May 31, 2024 | 27.40 | +1.48 |
Precise Biometrics | PREC | May 31, 2024 | 3.34 | +5.53 |
Precomp Solutions B | PCOMB | May 31, 2024 | 1.00 | +0.50 |
Premium Snacks Nordic | SNX | May 31, 2024 | 10.80 | -6.09 |
Preservia Holding PREF | PHOLPREF | May 31, 2024 | 11.40 | 0.00 |
Preservia Hyresfastigheter B | PHYRB | May 31, 2024 | 0.11 | 0.00 |
Preservia Hyresfastigheter PREF | PHYRPREF | May 31, 2024 | 42.40 | 0.00 |
Preservium Property | PRESRV | May 31, 2024 | 22.80 | 0.00 |
Prevas B | PREVB | May 31, 2024 | 141.20 | +1.00 |
Pricer B | PRICB | May 31, 2024 | 12.66 | +5.85 |
Proact IT Group | PACT | May 31, 2024 | 142.80 | +2.15 |
Probi | PROB | May 31, 2024 | 218.00 | -1.80 |
ProfilGruppen B | PROFB | May 31, 2024 | 125.00 | -0.79 |
Profoto Holding | PRFO | May 31, 2024 | 68.00 | +1.19 |
Projektengagemang Sweden B | PENGB | May 31, 2024 | 12.90 | -3.37 |
Prolight Diagnostics | PRLD | May 31, 2024 | 0.14 | +23.93 |
Promimic AB | PRO | May 31, 2024 | 32.30 | -1.22 |
ProstaLund | PLUN | May 31, 2024 | 0.65 | +17.88 |
Prostatype Genomics | PROGEN | May 31, 2024 | 0.06 | -3.73 |
Provide IT | PROVIT | May 31, 2024 | 1.79 | -3.24 |
Purefun | PURE | May 31, 2024 | 11.05 | -0.90 |
Q-Linea | QLINEA | May 31, 2024 | 2.44 | -0.41 |
QBank | QBNK | May 31, 2024 | 6.75 | +12.50 |
Qbrick | QBRICK | May 31, 2024 | 0.23 | -4.96 |
Qiiwi Games | QIIWI | May 31, 2024 | 1.87 | +4.18 |
QleanAir | QAIR | May 31, 2024 | 32.70 | 0.00 |
Qlife Holding | QLIFE | May 31, 2024 | 0.00 | 0.00 |
Qliro | QLIRO | May 31, 2024 | 22.50 | +0.22 |
Qlosr Group B | QLOSRB | May 31, 2024 | 0.80 | +4.16 |
Qlucore | QCORE | May 31, 2024 | 8.60 | +0.58 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.